Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive and Behavioral Dysfunction in Huntington's Disease
NCT00652457Phase 4Completed
- Start
- Nov 2004
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Huntington's disease (HD) comparing Memantine with Placebo (2 arms). Primary endpoint: Hopkins Verbal Learning Test - Revised for Delayed Recall at 6 months. Started Nov 2004; status: completed.
02
Drugs
memantine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00652457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652457.